Durango, Colorado, cyclist Mark Gouge told Escape Collective he injected BPC-157 and TB-500 on a protocol from a riding friend after a second shoulder surgery this year and was back on his bike within six weeks, which he credits to the peptides. The cycling outlet reported on November 10 that such use is spreading through influencer promotion and gray-market sales, even though most popular peptides have not been approved for human use, have little rigorous human testing, and are banned in competitive sport.
The Precision Peptide Company (BPC) announced a strategic exclusive marketing partnership on May 8 with Mixed Martial Arts Group Limited (MMA), covering distribution of BPC's peptide product line through MMA's network of approximately 530,000 user profiles, 75,000 active students, and 800 verified gyms globally. The revenue-sharing arrangement splits net revenue 50/50 between the two companies for the first 12 months, then shifts to 75% BPC / 25% MMA for the remainder of the term. The deal taps into the broader consumer peptide wellness market projected to approach $300B (per the May 12 GlobeNewswire industry report) and signals the increasingly mainstream integration of peptide products into the combat-sports and broader athletic-performance distribution channels ahead of the July 23-24 PCAC meeting.